Publications by authors named "Stefanie Perez"

Healthcare workers face greater risks for mental health conditions and chronic stress due to the demanding nature of their roles. The COVID-19 pandemic exacerbated these challenges and increased vulnerabilities to long-term mental health conditions. The present study adapts an existing resilience-based educational workshop program to address the time constraints and unique needs of the healthcare workforce in a post-COVID-19 world.

View Article and Find Full Text PDF

Understanding HIV latent reservoirs in tissues is essential for the development of new strategies targeting these sites for eradication. Here, we assessed the size of latent reservoirs and the source of residual viruses in multiple lymphoid tissues of SIV-infected and fully suppressed rhesus macaques of Chinese-origin (cRMs). Eight cRMs were infected with SIVmac251 and treated with tenofovir and emtricitabine daily for 24 weeks initiated 4 weeks post-infection.

View Article and Find Full Text PDF

Persistence of HIV-1 reservoirs in the central nervous system (CNS) is an obstacle to cure strategies. However, little is known about residual viral distribution, viral replication levels, and genetic diversity in different brain regions of HIV-infected individuals on combination antiretroviral therapy (cART). Because myeloid cells particularly microglia are likely major reservoirs in the brain, and more microglia exist in white matter than gray matter in a human brain, we hypothesized the major viral reservoirs in the brain are the white matter reflected by higher levels of viral DNA.

View Article and Find Full Text PDF
Article Synopsis
  • Phosphoglucomutase-1 deficiency (PGM1-CDG) is a type of genetic disorder, and a pilot study was conducted to evaluate the effects of oral D-galactose (D-gal) supplementation on nine patients with this condition.
  • The study involved increasing D-gal intake to 1.5 g/kg/day over 18 weeks, monitoring safety and improvements in various health markers; results showed that eight patients had no adverse effects and experienced improvements in liver and coagulation function.
  • In vitro tests demonstrated that D-gal treatment helped correct cellular glycosylation issues, improving overall glycoprotein profiles and suggesting that D-gal is a safe and effective treatment for PGM1
View Article and Find Full Text PDF